Risk Paradigm Group’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

Risk Paradigm Group’s Portfolio CNCR Stock Details CNCR Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell
2018 Q1	$77K	Buy
2017 Q4	$46.4K	Buy
2017 Q3	–	Sell
2017 Q2	$16.1K	Buy